Cardiogen is a synthetic cardiovascular bioregulator tetrapeptide (AEDR: Ala-Glu-Asp-Arg) studied for its cellular repair and cardioprotective properties. It enters cells and modulates fundamental survival pathways, supporting cytoskeletal integrity and reducing apoptosis in stressed cardiac tissue.
Quickstart Highlights
- Dosage: 200-500mcg
- Frequency: Daily
- Administration: Subcutaneous
- Cycle length: 8-16 weeks
Dosing Plan
| Weeks | Dose | Units |
|---|---|---|
| Weeks 1–2 | 200mcg | 3 units (0.03mL) |
| Weeks 3–8 | 300mcg | 4.5 units (0.045mL) |
| Weeks 9–16 | 500mcg | 7.5 units (0.075mL) |
How to mix
Add 3.0mL bacteriostatic water per 20mg vial → ~6.67mg/mL concentration
- Draw 3.0mL bacteriostatic water with a sterile syringe.
- Inject slowly down the vial wall.
- Gently swirl until dissolved.
- Label with date and refrigerate at 2–8°C.
Syringe Math Reference
- 20mg vial with 3mL BAC water = 6.67 mg/mL
- 1 unit = 0.01mL ≈ 66.7mcg
- 200mcg = 3 units
- 300mcg = 4.5 units
- 500mcg = 7.5 units
What you'll need
Cardiogen Vials (20mg)
- 8 weeks 1 vial
- 16 weeks 2 vials
Insulin Syringes (U-100)
- 8 weeks 60 syringes
- 16 weeks 120 syringes
Bacteriostatic Water (10mL)
- 16 weeks 1 bottle
Alcohol Swabs
- 16 weeks 2 × 100-count boxes
How This Works
Cardiogen (Ala-Glu-Asp-Arg) is a synthetic tetrapeptide that acts as a bioregulator for cardiac tissue. It penetrates cell membranes and modulates gene expression related to cellular survival, cytoskeletal integrity, and apoptosis. Preclinical research indicates it may protect cardiomyocytes from stress-induced damage.
Mechanism of Action
How Cardiogen Works in Your Body
Peptide Administered
Enters the bloodstream via injection
Receptor Binding
Finds and activates its target receptor
Signal Cascade
Triggers a chain of cellular responses
Biological Effect
The body produces the desired outcome
Benefits & Side Effects
Potential Benefits
- Cardioprotective effects
- Reduced cardiac cell apoptosis
- Cytoskeletal support
- Cellular repair in heart tissue
- Anti-aging effects on cardiovascular system
Potential Side Effects
- Generally well tolerated
- Injection site reactions (rare)
- Limited human clinical data
How to store it
- Lyophilized: Freeze at −20°C (−4°F).
- Reconstituted: Refrigerate at 2–8°C.
- Avoid freeze–thaw cycles.
Good to know
- Part of the Khavinson bioregulator peptide class.
- Supports cardiac tissue through modulation of survival pathways.
- Reduces apoptosis in stressed cardiac cells.
- May support cytoskeletal integrity.
- Low-dose plan that builds up slowly.
Community Insights
Summarised from 2 sourcesCardiogen is a synthetic cardiovascular bioregulator tetrapeptide (AEDR: Ala-Glu-Asp-Arg) studied for its cellular repair and cardioprotective properties. It enters cells and modulates fundamental survival pathways, supporting cytoskeletal integrity and reducing apoptosis in stressed cardiac tissue.
Common Dosages Reported
- 200-500mcg Daily
- Standard protocol dosing
Side Effects Mentioned
- Generally mild, individual variation expected
- See full guide for detailed safety info
Stacking Suggestions
- Consult research and healthcare provider before stacking
What people are saying
Results vary based on individual response
Consistent dosing and timing important
Reviews & Discussion
Real experiences shared by the community — not medical advice.
Cardiogen for Cardiovascular Regeneration
A user included Cardiogen in a comprehensive list of peptides, noting its primary use for heart health and cardiovascular system regeneration. The report highlights its potential for improving heart muscle metabolism and increasing exercise tolerance.
Cardiogen Technical Overview and Usage
A resource list describes Cardiogen as a peptide primarily used for cardiovascular health and heart tissue repair. It is noted as having foreign approval (specifically in Russia) rather than US FDA approval.
Cardiogen usage and comparison to Vesugen
A user discussed the specific application of Cardiogen, noting that it is intended strictly for heart regulation while a related peptide, Vesugen, focuses on blood vessels. They suggested that the bioregulator can provide significant benefits when administered at sufficiently high dosages for a period of one to three months.
No discussion yet — be the first.
No notes yet — be the first.